Inflammatory Markers Market

Inflammatory markers: Market Insights

Inflammatory markers are used in the assessment of cancer and other chronic diseases. Inflammation markers raise in the inflammatory conditions. C reactive protein and interleukin are the most common form of inflammatory markers.

Some of the common inflammatory conditions include rheumatoid arthritis, tissue injury and burns, Crohn's disease, cancer, etc.

Introduction of an infectious organism including mycobacterium tuberculosis, protozoa, fungi, and other parasites that can resist host defenses and remain in the tissue for an extended period, is one of the major cause of chronic inflammation.

Other causes of chronic inflammation include exposure to a low level of particular irritant and foreign particles, autoimmune diseases, in which the immune system is sensitized. Chronic inflammation can be caused due to repeated episodes of acute inflammation.

Inflammatory markers: Market Dynamics

Increasing prevalence of cancer is one of the major factors, responsible for the significant growth of inflammatory markers market. Increasing population especially in developing regions and increasing prevalence of other chronic diseases, is expected to increase the growth of inflammatory markers market. Increasing research and developmental activities is another important factor which can drive the growth of inflammatory markers market.

Other factors such as increasing healthcare awareness, an increasing number of hospitals and research laboratories, etc. are expected to increase the growth of inflammatory markers market. Increasing government initiatives and increasing government funding for the research activities, is a very important factor which can increase the growth of inflammatory markers market.

An increasing number of diagnostic laboratories is expected to increase the growth of global inflammation markers market.

There are a few factors, which can restrain the growth of inflammatory markers market. Lack of healthcare awareness in some of the emerging regions is expected to increase the growth of the global inflammatory markers market.

Global Inflammatory markers Market: Overview

Based on product type, inflammatory markers market has been segmented into interlukins, C reactive proteins, lepitine, cellular adhesion molecules, tumor necrosis factors and others. Interlukins are expected to hold a large revenue share in the global inflammatory markers market.

Based on the indications, the global inflammatory markers market has been segmented into tumors, arthritis, multiple sclerosis, diabetes and various other applications. Tumors are expected to hold a large revenue share in the overall inflammatory markers market.

Based on the end user, the inflammatory markers market has been segmented into hospitals, clinics, research laboratories and others. Research laboratories are expected to hold a significant share in the global inflammatory markers market.

Global Inflammatory markers Market: Region-wise Outlook

On the basis of geography, global inflammatory markers market is segmented into several key regions viz. North America, Latin America, Europe, East Asia, South Asia, Oceania and Middle East and Africa. North America is expected to hold the largest shares in the inflammatory markers market primarily due to presence of well-established healthcare infrastructure and the presence of large number of research laboratories Europe is expected to hold a large revenue share in Inflammatory markers market due to increasing population and increasing prevalence of chronic diseases.

Asian countries are also expected to hold a significant growth rate in the forecast period due to increasing healthcare awareness among the people.

Inflammatory markers Market: Key Players

There are many companies manufacturing inflammatory markers. Some of the key players present in Global Inflammatory markers market are Merck and Co., Novartis International AG, Abnova, Cayman Chemical, Thermo Fisher Scientific, Cell Signaling Technology, Inc., Boditech Med Inc., LSI Medience Corporation, Abbott Diagnostics Inc., Siemens Healthcare Diagnostics Inc., BG Medicine Inc., LifeSign LLC.

The report covers exhaustive analysis on

• Inflammatory markers Market Segments
• Inflammatory markers Market Dynamics
• Inflammatory markers Market Size
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Value Chain

The regional analysis includes

• North America (U.S., Canada)
• Latin America (Mexico. Brazil)
• Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
• Eastern Europe (Poland, Russia)
• Asia-Pacific Excluding Japan (China, India, ASEAN, Australia & New Zealand)
• Japan
• The Middle East and Africa (GCC, S. Africa, N. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Global Inflammatory Market: Segmentation

Global Inflammatory markers is segmented by product type, indication and end user:

Segmentation by Product Type

• Interlukin
• Interlukin 6
• Interlukin 10
• Others
• C Reactive Protein
• Lepitine
• Cellular adhesion molecule
• Tumor necrosis factor-α
• Others

Segmentation by Indications

• Tumors
• Arthritis
• Multiple Sclerosis
• Diabetes
• Other Applications

Segmentation by End Users

• Hospitals
• Diagnostic Laboratories
• Research Laboratories
• Others